DUBLIN–(BUSINESS WIRE)–The “Digital Advertising Developments in Human Immunodeficiency Virus (HIV)” report has been added to ResearchAndMarkets.com’s providing.
Gilead’s Biktarvy.com achieved the very best visitors throughout branded HIV affected person websites within the US from April 2021 to March 2022, with about 3,800,000 visits, adopted by ViiV’s Dovato.com and Gilead’s Descovy.com. The best proportion of visitors to those websites originated from direct sources, adopted by referrals. Web sites for a number of manufacturers, together with Descovy, Cabenuva, Truvada, and Pifeltro, had related ranges of excessive direct visitors (53-57%), whereas Janssen’s Symtuza.com had the bottom (34%).
For affected person branded